HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1195245Generated: October 26, 2026
1-Heptyne → a-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-ol
https://huagongshe.com/reaction/1195245
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-Heptyne | HCID 12350 | — |
| Reactant | Leukotriene B4 | HCID 5280492 | — |
| Reactant | (-)-Glycidol | HCID 6973630 | — |
| Reactant | L-Ascorbic Acid | HCID 54670067 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Product | a-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-ol | HCID 14464847 | — |
Reaction Steps
The starting material for the process of this invention, compound 2, can be prepared as described in Nicolaou, K. C. et al., "A General and Stereocontrolled Total Synthesis of Leukotriene B4 and Analogues," J. Am. Chem. Soc., 106, 3548 (1984) or Hanson, R. M. and Sharpless, K. B., J. Org. Chem., 51 1922 (1986). Briefly, optically active (S)-glycidol THP ether is prepared from ascorbic acid as disclosed in Takano, S., Numata, H., Ogasawara, K., Heterocycles, 19, 237 (1982) and Baldwin, J. J., Raab, A. W., Mensler, K., Arison, B. H., McClure, D. E., J. Org. Chem., 43, 4876 (1978). The ether is reacted (-78-25° C.) with two equivalents of the anion of 1-heptyne (1.0 equiv. of n-BuLi, 1.0 equiv. of TMEDA and THF, -78° C.) to afford a-[(tetrahydro-2H-pyran-2-yl)oxy] dec-4-yn-2(R)-ol which is then silylated (t-BuPh2SiCl, imidazole, DMF) to , compound 2.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05110949 |
|---|
| Source dataset | uspto-grants-1992_05 |
|---|
| ORD ID | ord-b3da12420bdf42c095ff8497ef59c07f |
|---|
| Source note | uspto-grants-1992_05 |
|---|